Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited Ordinary Shares (NY:TEVA)

41.41 +0.69 (+1.68%)
Delayed Quote Updated: 11:05 AM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited Ordinary Shares

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
35 36 Next >
News headline image
US Stocks Set To Open Flat After Hot 7-Day Rally: Traders Sharpen Focus On Powell's Speech, Disney Earnings ↗
Stock futures indicate a subdued opening on Wednesday after several consecutive gains in major averages. Traders are eagerly awaiting Federal Reserve Chair Jerome Powell’s speech for insights into... 
Via Benzinga
Topics Economy
News headline image
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Earnings Scheduled For November 8, 2023 ↗
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Teva to Present New Data Supporting Safety, Efficacy and Real-World Effectiveness of AUSTEDO® (deutetrabenazine) Tablets at the 2023 HSG Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolongs Time to Schizophrenia Relapse in RISE Study Results Published in The Lancet Psychiatry
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Alkermes Q3 Earnings Top Consensus, On Track To Separate Oncology Business, Reaffirms FY23 Outlook ↗
Alkermes PLC (NASDAQ: ALKS) reported Q3 FY23 adjusted EPS of $0.64 compared to $0.02 a year ago, beating the  
Via Benzinga
News headline image
Teva to Provide Second Round of Funding to Clinics in California, Florida and New Jersey as Part of $2 Million Commitment Through Community Routes: Access to Mental Health Care Program
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Roche Spends $7.1 Billion On Roivant Drug, Following Merck, Sanofi Into The Raging Hot Immunology Space ↗
Roche is joining Merck and Sanofi in the TL1A drug space. These drugs could treat stomach diseases. 
Via Investor's Business Daily
News headline image
Israeli-Hamas War: U.S. Exchange-Listed Israeli Stocks Continue To Decline ↗
The 111 Israeli companies with stocks trading on US exchanges have combined market caps over $150B. Or at least they did midweek: since the Hamas-Israeli War began October 7th, pretty much everything... 
Via Talk Markets
News headline image
Investor Exit Israel ETFs Following Attacks, But Remain Confident In Large-Caps ↗
Israel-focused ETFs have plunged since the last trading day before Hamas launched surprise attacks on Israel, while some Israeli companies listed in the U.S. have so far escaped repercussions to their... 
Via Benzinga
Topics ETFs
News headline image
Thoughts For Thursday: War Worries Rattle The Market ↗
Via Talk Markets
News headline image
Hamas-Israeli War: US Exchange Listed Israeli Stocks Hit Hard ↗
111 Israeli companies trade on U.S. stock exchanges of which only 15 have market capitalization of $2B or more. 
Via Talk Markets
News headline image
Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Israel Could Form Emergency Government: Defense Stocks, Israel ETFs In Focus During Conflict ↗
As Israel ramps up its armed forces and a regional war with Hamas enters its fourth day, the country is considering forming an emergency government. 
Via Benzinga
Topics ETFs
News headline image
Israeli Stocks Fall as Investors Fear Middle East Conflict ↗
The recent attacks on Israel will have a lasting economic impact. Here's what investors should know about Israeli stocks. 
Via InvestorPlace
News headline image
Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch ↗
Discover how Cathie Wood's ARK Israel Innovative Tech ETF responds to the Israel-Hamas conflict. Explore its portfolio performance and top Israeli stocks to watch amidst geopolitical turmoil. 
Via Benzinga
Topics ETFs
News headline image
Why Teva Pharmaceutical (TEVA) Stock Is Falling ↗
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) shares are trading lower by 2.7% to $9.17 Monday morning amid conflict in the company's home country, Israel. 
Via Benzinga
News headline image
Middle East War Hammers Israel-Based Stocks But Lifts Defense, Oil Names ↗
Israel stocks, regardless of industry, sank Monday following the terrorist attack on Israel. 
Via Investor's Business Daily
News headline image
Teva to Host Conference Call to Discuss Third Quarter 2023 Financial Results at 8 a.m. ET on November 8, 2023
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories ↗
Benzinga 
Via Benzinga
News headline image
Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble. ↗
The deal leans into the emerging TL1A drug class, potentially rivaling Roivant and Merck. 
Via Investor's Business Daily
News headline image
Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People ↗
Sanofi SA (NASDAQ: SNY) and Teva Pharmaceutical Industries Ltd (NYSE: TEVA) have collaborated to co-develop and  
Via Benzinga
News headline image
Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Teva Announces Changes to Executive Management Team
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories ↗
Benzinga Alibaba's Logistics Arm Cainiao Files For Hong Kong IPO 
Via Benzinga
Topics Artificial Intelligence
News headline image
Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva ↗
A federal judge in Massachusetts has overturned a $176.5 million jury verdict against Eli Lilly And Co (NYSE: LLY). T 
Via Benzinga
Topics Intellectual Property
News headline image
Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report ↗
Despite significant initiatives by generic drug companies to broaden access to vital medicines, many vulnerable patients remain underserved, according to findings from a new study from the Access to... 
Via Benzinga
News headline image
3 No-Brainer Stocks to Buy With $20 Right Now ↗
You don't need a boatload of cash to begin growing your wealth on Wall Street. 
Via The Motley Fool
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.